Evaluation of BTX 1503 in Patients With Moderate to Severe Acne Vulgaris

Brief Summary:
The objective of this study is to assess safety and efficacy of various doses of BTX 1503 liquid formulation in subjects with moderate to severe acne vulgaris of the face.

 

Condition or disease  Intervention/treatment  Phase 
Acne Vulgaris Drug: BTX 1503Drug: Vehicle Phase 2

Detailed Description:

This will be a multi-center, randomized, double-blinded, vehicle-controlled, parallel group, dose-finding study in pediatrics, adolescents and adults (aged 12 to 40 years). The objective of this study is to assess the safety and efficacy of various doses of BTX 1503 in subjects with moderate to severe acne vulgaris of the face.
https://clinicaltrials.gov/ct2/show/NCT03573518
Leave a Reply
Easy 30 days returns

30 days money back guarantee

Quality Assurance

Offered in the country of usage

100% Secure Checkout

PayPal / MasterCard / Visa

© 2020 Vida Biologica. All Rights Reserved.